Cargando…

Chlorpromazine-induced perturbations of bile acids and free fatty acids in cholestatic liver injury prevented by the Chinese herbal compound Yin-Chen-Hao-Tang

BACKGROUNDS: Yin-Chen-Hao-Tang (YCHT), a commonly used as a traditional chinese medicine for liver disease. Several studies indicated that YCHT may improving hepatic triglyceride metabolism and anti-apoptotic response as well as decreasing oxidative stress .However, little is known about the role of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Qiaoling, Yang, Fan, Tang, Xiaowen, Ding, Lili, Xu, Ying, Xiong, Yinhua, Wang, Zhengtao, Yang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410582/ https://www.ncbi.nlm.nih.gov/pubmed/25887351 http://dx.doi.org/10.1186/s12906-015-0627-2

Ejemplares similares

Serum metabolomics strategy for understanding the therapeutic effects of Yin-Chen-Hao-Tang against Yanghuang syndrome
por: Liu, Xing-yuan, et al.
Publicado: (2018)

Serum Metabolomic Characterization of Liver Fibrosis in Rats and Anti-Fibrotic Effects of Yin-Chen-Hao-Tang
por: Zhang, Hongyang, et al.
Publicado: (2016)

Recent Studies and Progression of Yin Chen Hao (茵陳蒿 Yīn Chén Hāo), a Long-term Used Traditional Chinese Medicine
por: Hung, Hsin-Yi, et al.
Publicado: (2013)

Preclinical study of simultaneous pharmacokinetic and pharmacodynamic herb-drug interactions between Yin-Chen-Hao-Tang and spironolactone
por: Hsueh, Tun-Pin, et al.
Publicado: (2020)

Therapeutic mechanism of Yīn-Chén-Hāo decoction in hepatic diseases
por: Li, Jian-Yuan, et al.
Publicado: (2017)

Yin-Chen-Hao-Tang alleviates biliary obstructive cirrhosis in rats by inhibiting biliary epithelial cell proliferation and activation
por: Wang, Bing, et al.
Publicado: (2015)

Yin-Chen-Hao Tang Attenuates Severe Acute Pancreatitis in Rat: An Experimental Verification of In silico Network Target Prediction
por: Xiang, Hong, et al.
Publicado: (2016)

Corrigendum: Yin-Chen-Hao Tang Attenuates Severe Acute Pancreatitis in Rat: An Experimental Verification of In silico Network Target Prediction
por: Xiang, Hong, et al.
Publicado: (2018)

The Study of Yin-Chen-Hao-Tang Preventing and Treating Alcoholic Fatty Liver Disease through PPAR Signaling Pathway Based on Network Pharmacology and RNA-Seq Transcriptomics
por: Zhu, Yi-Wei, et al.
Publicado: (2021)

Development and Application of an UHPLC-MS/MS Method for Comparative Pharmacokinetic Study of Eight Major Bioactive Components from Yin Chen Hao Tang in Normal and Acute Liver Injured Rats
por: Wang, Yun, et al.
Publicado: (2018)

Corrigendum to “Development and Application of an UHPLC-MS/MS Method for Comparative Pharmacokinetic Study of Eight Major Bioactive Components from Yin Chen Hao Tang in Normal and Acute Liver Injured Rats”
por: Wang, Yun, et al.
Publicado: (2018)

Chen Quifan and Hao Ni visit CERN as guest artists
por: Saulsbury, Faye
Publicado: (2022)

The role of bile acids in cholestatic liver injury
por: Cai, Shi-Ying, et al.
Publicado: (2021)

Bile acid-mediated signaling in cholestatic liver diseases
por: Zeng, Jing, et al.
Publicado: (2023)

MRGPRX4 is a bile acid receptor for human cholestatic itch
por: Yu, Huasheng, et al.
Publicado: (2019)

Curcumin protects ANIT-induced cholestasis through signaling pathway of FXR-regulated bile acid and inflammation
por: Yang, Fan, et al.
Publicado: (2016)

Bile acids decrease intracellular bilirubin levels in the cholestatic liver: implications for bile acid-mediated oxidative stress
por: Muchova, Lucie, et al.
Publicado: (2011)

Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease
por: Shi, Qingmiao, et al.
Publicado: (2023)

Hormesis in Cholestatic Liver Disease; Preconditioning with Low Bile Acid Concentrations Protects against Bile Acid-Induced Toxicity
por: Verhaag, Esther M., et al.
Publicado: (2016)

Positive Effects of Ger-Gen-Chyn-Lian-Tang on Cholestatic Liver Fibrosis in Bile Duct Ligation-Challenged Mice
por: Chang, Zi-Yu, et al.
Publicado: (2019)

Studies on the mechanisms of bile acid initiated hepatic inflammation in cholestatic liver injury
por: Cai, Shi-Ying, et al.
Publicado: (2017)

Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis
por: Gui, Wenfang, et al.
Publicado: (2023)

An ErChen and YinChen Decoction Ameliorates High-Fat-Induced Nonalcoholic Steatohepatitis in Rats by Regulating JNK1 Signaling Pathway
por: Xie, Tian-hong, et al.
Publicado: (2017)

Yin Huo Tang, a traditional Chinese herbal formula, relives ovariectomy and empty bottle stimulation-induced menopause-like symptoms in mice
por: Ye, Yang, et al.
Publicado: (2022)

Retracted: An ErChen and YinChen Decoction Ameliorates High-Fat-Induced Nonalcoholic Steatohepatitis in Rats by Regulating JNK1 Signaling Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2019)

Ileal Bile Acid Transporter Inhibition for the Treatment of Chronic Constipation, Cholestatic Pruritus, and NASH
por: Al-Dury, Samer, et al.
Publicado: (2018)

Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancy
por: Ovadia, Caroline, et al.
Publicado: (2020)

The Yin and Yang of bile acid action on tight junctions in a model colonic epithelium
por: Sarathy, Jayashree, et al.
Publicado: (2017)

First person – Hao Lu
Publicado: (2020)

Profile of serum bile acids in non-cholestatic volunteers: gender-related differences in response to fenofibrate
por: Trottier, J., et al.
Publicado: (2011)

Pediatric Cholestatic Liver Disease: Review of Bile Acid Metabolism and Discussion of Current and Emerging Therapies
por: Kriegermeier, Alyssa, et al.
Publicado: (2020)

Bile acid nuclear receptor FXR and digestive system diseases
por: Ding, Lili, et al.
Publicado: (2015)

18β-Glycyrrhetinic Acid Protects against Cholestatic Liver Injury in Bile Duct-Ligated Rats
por: Pan, Pin-Ho, et al.
Publicado: (2022)

Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2(−/−) mice by modulating composition, signalling and excretion of faecal bile acids
por: Fuchs, Claudia Daniela, et al.
Publicado: (2018)

ECT-CHLORPROMAZINE COMBINATION COMPARED WITH CHLORPROMAZINE ONLY IN SCHIZOPHRENIA1
por: Janakiramaiah, N., et al.
Publicado: (1981)

Bile Nephropathy in Flucloxacillin-Induced Cholestatic Liver Dysfunction
por: Alnasrallah, Basil, et al.
Publicado: (2016)

Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease
por: Tyc, Olaf, et al.
Publicado: (2020)

Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2(−/−) mouse model of sclerosing cholangitis via immunomodulatory effects
por: Fuchs, Claudia D., et al.
Publicado: (2022)

PHB2 interacts with LC3 and SQSTM1 is required for bile acids-induced mitophagy in cholestatic liver
por: Xiao, Yongtao, et al.
Publicado: (2018)

Urinary Elimination of Bile Acid Glucuronides under Severe Cholestatic Situations: Contribution of Hepatic and Renal Glucuronidation Reactions
por: Perreault, Martin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p3ptiqdqs6br4f5tmdp70pjtu8